Media coverage about Transcat (NASDAQ:TRNS) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Transcat earned a news impact score of 0.08 on Accern’s scale. Accern also assigned news coverage about the scientific and technical instruments company an impact score of 46.2079953983304 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Shares of Transcat traded down $0.65, hitting $19.95, on Friday, MarketBeat reports. The stock had a trading volume of 21,454 shares, compared to its average volume of 31,171. Transcat has a twelve month low of $11.95 and a twelve month high of $21.14. The firm has a market capitalization of $148.27 million, a price-to-earnings ratio of 28.10, a price-to-earnings-growth ratio of 2.77 and a beta of 0.42. The company has a quick ratio of 1.32, a current ratio of 1.92 and a debt-to-equity ratio of 0.40.
Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Wednesday, May 23rd. The scientific and technical instruments company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.04. Transcat had a net margin of 3.82% and a return on equity of 10.83%. The company had revenue of $42.45 million during the quarter, compared to analyst estimates of $40.70 million. research analysts expect that Transcat will post 0.93 earnings per share for the current year.
In related news, Director Alan H. Resnick sold 1,916 shares of the company’s stock in a transaction on Friday, June 8th. The shares were sold at an average price of $19.79, for a total value of $37,917.64. Following the completion of the transaction, the director now directly owns 35,400 shares of the company’s stock, valued at approximately $700,566. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Charles P. Hadeed sold 17,700 shares of the company’s stock in a transaction on Wednesday, May 30th. The stock was sold at an average price of $18.18, for a total transaction of $321,786.00. Following the completion of the transaction, the chairman now directly owns 77,474 shares of the company’s stock, valued at $1,408,477.32. The disclosure for this sale can be found here. 8.80% of the stock is owned by insiders.
Transcat Company Profile
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services.
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.